New combo therapy aims to make inoperable liver cancer operable
NCT ID NCT07368023
First seen Jan 30, 2026 · Last updated Apr 25, 2026 · Updated 10 times
Summary
This study looks back at medical records of 300 people with liver cancer that could not be removed by surgery. About 100 patients received a mix of local treatments (like TACE or radiation) plus targeted drugs and immunotherapy, hoping to shrink the tumors enough to allow surgery. The other 200 patients had surgery right away. The goal is to see how well the combination therapy works and if it is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ningbo Medical Centre Lihuili Hospital
Ningbo, Zhejiang, 315000, China
Conditions
Explore the condition pages connected to this study.